Global Perspectives of Pharmacy Education and Practice

被引:21
作者
Anderson, Claire [1 ]
Bates, Ian [2 ]
Futter, Billy [3 ]
Gal, Diane [4 ]
Rouse, Mike [5 ]
Whitmarsh, Sarah [6 ]
机构
[1] Univ Nottingham, Nottingham, England
[2] Univ London, FIP Collaborating Ctr, London, England
[3] Rhodes Univ, Grahamstown, South Africa
[4] Int Pharmaceut Federat, The Hague, Netherlands
[5] Accreditat Council Pharm Educ, Chicago, IL USA
[6] Univ London, London, England
关键词
pharmacy; education; needs-based education; education development; academic capacity; quality assurance; competency;
D O I
10.2202/1948-4682.1052
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Pharmacists have been shown to reduce morbidity and mortality, reduce medication errors, improve rational use and prescribing of medicines, and increase access to health care and medicines. Unfortunately, in many countries there is a severe shortage of appropriately trained pharmacists and pharmaceutical human resources. The WHO UNESCO FIP Pharmacy Education Taskforce is steering sustainable pharmacy education and pharmacy workforce action to support and strengthen local, national, regional, and international efforts. The Taskforce advocates for a needs-based approach, which aims to meet the pharmaceutical needs of the local population. This paper explains the concept of needs-based education, describes the work of the Pharmacy Education Taskforce, and explores key issues in pharmacy education development and quality assurance.
引用
收藏
页码:5 / 18
页数:14
相关论文
共 29 条
[1]   Defining characteristics of educational competencies [J].
Albanese, Mark A. ;
Mejicano, George ;
Mullan, Patricia ;
Kokotailo, Patricia ;
Gruppen, Larry .
MEDICAL EDUCATION, 2008, 42 (03) :248-255
[2]  
Anderson C., 2009, PHARMACYHEALTHLINK
[3]  
Anderson C., 2006, INT PHARM J, V20, P12, DOI [10.5688/aj7206127, DOI 10.5688/AJ7206127]
[4]   Economic impact of increased clinical intervention rates in community pharmacy - A randomised trial of the effect of education and a professional allowance [J].
Benrimoj, SI ;
Langford, JH ;
Berry, G ;
Collins, D ;
Lauchlan, R ;
Stewart, K ;
Aristides, M ;
Dobson, M .
PHARMACOECONOMICS, 2000, 18 (05) :459-468
[5]   Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease [J].
Blenkinsopp, A ;
Anderson, C ;
Armstrong, M .
JOURNAL OF PUBLIC HEALTH MEDICINE, 2003, 25 (02) :144-153
[6]   Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals [J].
Bond, C. A. ;
Raehl, Cynthia L. .
PHARMACOTHERAPY, 2006, 26 (06) :735-747
[7]   Staffing and the cost of clinical and hospital pharmacy services in United States hospitals [J].
Bond, CA ;
Raehl, CL ;
Pitterle, ME .
PHARMACOTHERAPY, 1999, 19 (06) :767-781
[8]   Clinical pharmacy services and hospital mortality rates [J].
Bond, CA ;
Raehl, CL ;
Franke, T .
PHARMACOTHERAPY, 1999, 19 (05) :556-564
[9]   Interrelationships among mortality rates, drug costs, total cost of care, and length of stay in United States hospitals: Summary and recommendations for clinical pharmacy services and staffing [J].
Bond, CA ;
Raehl, CL ;
Franke, T .
PHARMACOTHERAPY, 2001, 21 (02) :129-141
[10]   Clinical pharmacy services, pharmacist staffing, and drug costs in United States hospitals [J].
Bond, CA ;
Raehl, CL ;
Franke, T .
PHARMACOTHERAPY, 1999, 19 (12) :1354-1362